Position in CGEN
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$28,637
-$16,727 QoQ
Shares Held
13,445
-54.7% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026R Squared Ltd holds $4,187,945 across 33 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,337 | $664,128 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
902 | $562,433 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
5,313 | $421,267 | |
| 4 | MRNA |
Moderna, Inc.
|
5,647 | $395,459 | |
| 5 | NTLA |
Intellia Therapeutics, Inc.
|
15,246 | $257,962 | |
| 6 | BLTE |
Belite Bio, Inc
|
1,338 | $206,031 | |
| 7 | CYTK |
Cytokinetics Inc
|
2,350 | $200,196 | |
| 8 | MESO |
Mesoblast Ltd
|
14,492 | $196,076 |
All Filings in CGEN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,637 | 13,445 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $45,364 | 29,650 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $56,184 | 38,221 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $71,214 | 40,008 | Shares | Sole | 2025-07-31 | |
| 2024-12-31 | $4,085 | 2,670 | Shares | Sole | 2025-01-23 | |
| No filing history on record for this holder in this stock. | ||||||